About

Dr. Wei‐Chun Weng is a pioneering urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for prostate and renal cancers, with a particular focus on expanding treatment indications and improving surgical outcomes. His most impactful contributions include being the first in Taiwan and Northeast Asia to perform robot-assisted radical prostatectomy using the Hugo RAS system (20 citations), demonstrating the feasibility of this novel platform. Dr. Weng has also made significant strides in validating robotic-assisted ureteroplasty with buccal mucosa grafts for ureteral strictures (13 citations), and in developing predictive nomograms for prostate cancer detection (7 citations). With over 2,000 robotic prostatectomies performed, his comprehensive analysis of complications (4 citations) provides invaluable safety data for the field. Beyond urology, he has contributed to gastrointestinal diagnostics through a review of capsule endoscopy advancements (10 citations). Dr. Weng’s work consistently emphasizes clinical innovation, patient safety, and the expansion of robotic surgery’s role in complex urologic conditions, making him a leading figure in Asian robotic urology.

Research Focus

Key Achievements

6
H-Index
15
Papers
98
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted radical prostatectomy using hugo RAS system: The pioneer experience in Taiwan and Northeast Asia
20 citations · 2023
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 44
🏛 Institutions: Mackay Junior College of Medicine, Nursing and Management, Kaohsiung Armed Forces General Hospital, Taichung Veterans General Hospital, Tungs' Taichung MetroHarbor Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago